Technology Transfer at Columbia
Columbia Technology Ventures is the technology transfer office of Columbia University, located in New York City. Our core objective is to facilitate the transfer of inventions from academic research to outside organizations for the benefit of society on a local, national and global basis. Read our mission statement here.
Each year, CTV manages more than 375 invention disclosures from researchers, 100 license deals and 18 new start-ups, involving over 750 inventors across Columbia's campuses. CTV currently has over 1200 patent assets available for licensing, across research fields such as bio, IT, cleantech, devices, big data, nanotechnology, materials science, and more. We also work closely with our colleagues from other New York City academic institutions on initiatives like the PowerBridgeNY clean energy proof-of-concept center, the NYC Media Lab, and the New York Academic Consortium Health and Biotech Summit.
Columbia Technology Ventures has a particular focus on start-up companies. Over the years, CTV has been involved with launching over 150 companies based on Columbia's technologies. Of these companies, over 40 have received VC funding, with over 25 successful acquisitions or IPOs to date.
Products Enabled by Columbia Innovation
Many of Columbia’s inventions have become integrated into life-saving or life-enhancing products available to consumers globally, including: Remicade; ReoPro; Tysabri; Zolinza; Synagis; Xalatan; Xalcom; Epogen; Avonex; Herceptin; Arrow catheters; MPEG-2; and in Blackberry and Apple products.
To learn more about our technologies or to submit an invention report, please contact a member of our licensing team, or email firstname.lastname@example.org.